Institut Bergonié
🇫🇷France
- Country
- 🇫🇷France
- Ownership
- Private
- Established
- 1923-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.bergonie.org
Randomized Phase II Trial on Short Term Darolutamide Concomitant to Radiation Therapy for Patients With Intermediate Unfavorable Risk Prostate Cancer
Phase 2
Recruiting
- Conditions
- Prostate Cancer
- Interventions
- Drug: Association of ADT and EBRTDrug: Association of darolutamide and EBRT
- First Posted Date
- 2022-04-26
- Last Posted Date
- 2023-03-03
- Lead Sponsor
- Institut Bergonié
- Target Recruit Count
- 62
- Registration Number
- NCT05346848
- Locations
- 🇫🇷
Institut Bergonie, Bordeaux, France
🇫🇷Sainte Catherine, Institut du Cancer Avignon-Provence, Avignon, France
🇫🇷CHRU Brest - Hôpital Morvan, Brest, France
Combination of Pembrolizumab and Cabozantinib in Patients With Advanced Sarcomas
Phase 2
Recruiting
- Conditions
- Ewing SarcomaUndifferentiated Pleomorphic SarcomaOsteosarcomaAdvanced Soft-tissue SarcomaSoft Tissue Sarcoma Adult
- Interventions
- First Posted Date
- 2022-01-10
- Last Posted Date
- 2023-09-28
- Lead Sponsor
- Institut Bergonié
- Target Recruit Count
- 119
- Registration Number
- NCT05182164
- Locations
- 🇫🇷
Institut Bergonie, Bordeaux, France
🇫🇷Centre Leon Berard, Lyon, France
🇫🇷Hôpital La Timone, Marseille, France
Health Literacy and Digital Health in Cancer Patients.
Completed
- Conditions
- Cancer
- Interventions
- Other: Questionnaires
- First Posted Date
- 2021-10-07
- Last Posted Date
- 2024-06-12
- Lead Sponsor
- Institut Bergonié
- Target Recruit Count
- 1518
- Registration Number
- NCT05070897
- Locations
- 🇫🇷
Pr Elene Paillaud, Paris, France
A Public Health Intervention Program to Improve the Initial Management of Soft Tissue Sarcomas.
Completed
- Conditions
- Sarcoma
- Interventions
- Other: No public Health intervention programmeOther: Public Health intervention programme
- First Posted Date
- 2021-08-16
- Last Posted Date
- 2022-01-11
- Lead Sponsor
- Institut Bergonié
- Target Recruit Count
- 274
- Registration Number
- NCT05007639
Neoadjuvant Chemotherapy and Retifanlimab in Patients With Selected Sarcomas (TORNADO)
Phase 2
Recruiting
- Conditions
- Resectable Sarcoma
- Interventions
- First Posted Date
- 2021-07-20
- Last Posted Date
- 2023-03-03
- Lead Sponsor
- Institut Bergonié
- Target Recruit Count
- 66
- Registration Number
- NCT04968106
- Locations
- 🇫🇷
Institut Bergonié, Bordeaux, France
🇫🇷Centre Léon Bérard, Lyon, France
🇫🇷Institut Curie, Paris, France
Remote Monitoring for Ambulatory Care of Elderly Patients With Cancer
Not Applicable
Active, not recruiting
- Conditions
- Cancer
- Interventions
- Other: Remote monitoring
- First Posted Date
- 2021-06-04
- Last Posted Date
- 2024-11-18
- Lead Sponsor
- Institut Bergonié
- Target Recruit Count
- 33
- Registration Number
- NCT04913259
- Locations
- 🇫🇷
Institut Bergonie, Bordeaux, France
Implementing Circulating Tumor DNA Analysis at Initial Diagnosis to Improve Management of Advanced NSCLC Patients
Not Applicable
Recruiting
- Conditions
- Advanced Solid TumorNon Small Cell Lung Cancer
- Interventions
- Diagnostic Test: EGFR gene mutation analysis on liquid biopsy
- First Posted Date
- 2021-06-03
- Last Posted Date
- 2023-03-01
- Lead Sponsor
- Institut Bergonié
- Target Recruit Count
- 580
- Registration Number
- NCT04912687
- Locations
- 🇫🇷
Institut Curie, Paris, France
🇫🇷CHRU Lille, Lille, France
🇫🇷Institut Bergonie, Bordeaux, France
Impact of Specific Monitoring of Intraoperative Analgesia Under General Anesthesia on Chronic Pain After Ovarian Cancer Surgery
Not Applicable
Recruiting
- Conditions
- Ovarian Neoplasm
- First Posted Date
- 2021-05-28
- Last Posted Date
- 2024-11-18
- Lead Sponsor
- Institut Bergonié
- Target Recruit Count
- 126
- Registration Number
- NCT04906187
- Locations
- 🇫🇷
Institut Bergonié, Bordeaux, France
Integrative Analysis of Tumor Microenvironment and Optimization of Immunotherapy Duration in NSCL Cancer Patients
Phase 2
Active, not recruiting
- Conditions
- Non Small Cell Lung Cancer
- Interventions
- Drug: ICI treatment continuationDrug: ICI treatment discontinuation
- First Posted Date
- 2021-05-10
- Last Posted Date
- 2024-01-30
- Lead Sponsor
- Institut Bergonié
- Target Recruit Count
- 80
- Registration Number
- NCT04880382
- Locations
- 🇫🇷
Clinique Tivoli Ducos, Bordeaux, France
🇫🇷Institut Bergonie, Bordeaux, France
🇫🇷Polyclinique Bordeaux Nord Aquitaine, Bordeaux, France
Bintrafusp Alfa and Doxorubicin Hydrochloride in Treating Patients With Advanced Sarcoma
Phase 2
Recruiting
- Conditions
- Advanced Soft-tissue SarcomaMetastatic Soft-tissue Sarcoma
- Interventions
- First Posted Date
- 2021-05-05
- Last Posted Date
- 2023-09-28
- Lead Sponsor
- Institut Bergonié
- Target Recruit Count
- 80
- Registration Number
- NCT04874311
- Locations
- 🇫🇷
Centre Georges François Leclerc, Dijon, France
🇫🇷Institut Paoli Calmette, Marseille, France
🇫🇷Institut Curie, Paris, France
© Copyright 2025. All Rights Reserved by MedPath